NSE: WOCKPHARMA | BSE: 532300

Expensive Performer

Download real time

1361.90 -1.70 (-0.12%)

27.12% Fall from 52W High

193.7K NSE+BSE Volume

NSE 27 Feb, 2026 3:31 PM (IST)

22,129.8

Market Cap

High in industry

Beta 1Year

Very High Volatility

Wockhardt Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for WOCKPHARMA, BSE:532300 Wockhardt Ltd.

Search Inside the pdf :

Wockhardt Ltd.

08 Jul 2025

1361.90

-0.12%

Axis Punch:Wockhardt

Buy: Wockhardt Ltd.

Axis Direct

We recommend a BUY rating on the stock, with a target price of Rs 1,870/share reflecting 10% upside potential from the CMP.

Number of FII/FPI investors decreased from 186 to 179 in Dec 2025 qtr

Wockhardt Ltd.

31 Jan 2018, 05:49PM

1361.90

-0.12%

Wockhardt Ltd Q3FY18 results comment

Results Update: Wockhardt Ltd.

HDFC Securities

Wockhardt Ltd Q3FY18 results comment Revenue decreased by 1.66% to Rs. 1005.3 Cr in Q3FY18 when compared to the previous quarter

Wockhardt Ltd. has an average target of 1870.00 from 1 broker.

Wockhardt Ltd.

23 May 2017

1361.90

-0.12%

Wockhardt Ltd Q4FY17 results comment

Results Update: Wockhardt Ltd.

HDFC Securities

Revenue fell by 13.26% to Rs. 863.53 Cr in Q4FY17 when compared to the previous quarter.

Wockhardt Ltd. is trading below all available SMAs

Wockhardt Ltd.

31 Jan 2017, 05:25PM

1361.90

-0.12%

Wockhardt Ltd Q3FY17 results comment

Results Update: Wockhardt Ltd.

HDFC Securities

Revenue fell by 6.49% to Rs. 995.56 Cr in Q3FY17 when compared to the previous quarter. Also, it decreased by 7.35% when compared with Q3FY16.

Number of FII/FPI investors decreased from 186 to 179 in Dec 2025 qtr

Is Wockhardt Ltd. worth buying?

460 Votes:

Buy 73.48%

Sell 17.17%

Hold 9.35%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Results Update SEE REPORTS >

pdf